Objective To provide an update on rubella and pregnancy so that health professionals
remain aware of the potentially devastating effects on the developing fetus. Outcomes …

Aim: This study of pregnant women was undertaken to clarify their immune status for rubella
and to evaluate the efficacy of, and adverse reaction to, post‐partum rubella vaccination …

Background: Rubella infection during the first trimester results in congenital rubella
syndrome. There has been little recent published evidence identifying those at‐risk of …

Objective The aim of this study was to examine the relationship between BMI and the
incidence of rubella nonimmunity among pregnant women with regard to the World Health …

Rubella is usually a mild infectious disease, often accompanied by a rash. In pregnant
women, however, rubella infection can result in miscarriage, stillbirth, and a series of …

Vaccination is considered the most effective method to prevent rubella spread and
congenital rubella syndrome (CRS). The aim of the present study was to investigate the …

Rubella is the first virus demonstrated as a teratogen. There is a high risk to develop
congenital rubella syndrome (CRS) if the infection occurs in the first part of pregnancy …

Objective: The major purpose of the study was to determine the number of rubella‐
susceptible women attending an urban family‐planning clinic. Design: A retrospective …

Rubella causes disease in the fetus. Immunity to rubella is therefore, routinely screened in
pregnant women. In this retrospective observational study, we assessed the levels of …

Rubella infection during the first trimester of pregnancy can cause congenital rubella
syndrome in the fetus. This can be prevented with the live attenuated rubella vaccine given …